Madison, WI, United States
Madison, WI, United States

Time filter

Source Type

News Article | May 8, 2017
Site: www.biosciencetechnology.com

A new automated, high-performance cell washer has been specifically designed to enable precise, thorough, reproducible and rapid blood cell washing of up to 24 tubes in a three-minute run. Fully automated, the Thermo Scientific CW3 Cell Washer has been uniquely engineered to combine the benefits of efficient performance with user-friendly design and safe operation. Users can select one of the pre-set programs that have been designed to run in automatic mode, accelerate blood cell washing cycles and achieve significant time savings, while allowing for maximum ease of use and sample safety. “Effective blood cell washing is extremely important in the removal of plasma and unwanted antibodies to ensure that patients will not be affected by adverse health effects and that blood-transfused products will retain all of their beneficial attributes,” said Hugh Tansey, global product director, centrifugation, Thermo Fisher Scientific. “To address this issue, we’ve developed a novel cell washer to help clinical, hospital and serological laboratories, as well as blood bank and transfusion centers, fulfill their fundamental mission to promote the well-being of patients.” The cell washer has been designed to achieve optimal corpuscle dryness by allowing users to pre-set the desired decanting speed. At the same time, corpuscle washing is improved via the optional overflow method. For washing, tubes swing at a fixed positive angle to sediment cells rapidly at the bottom of the tube, whereas when decanting, the rotor holds tubes at a slightly negative angle and the saline is decanted centrifugally. The result is optimized pelleting performance. Furthermore, the flexibility to use 12- or 24-place rotors and standardized, repeatable procedures enables the instrument to adapt to the processes and protocols already in place within the lab. Built with sample safety in mind, the compact unit features an automatic alert mechanism that informs users about low or disrupted saline levels and when a run is complete. A view port on top of the unit facilitates quick calibration, while the saline distributor is mounted directly on top of the rotor to reduce the risk of cross-contamination. The new washer is also equipped with tube racks bearing red and blue number labeling for easy sample balancing. In addition, when closed-monitoring of the washing process is required, the system can be operated manually to allow for cells that need to be washed step-by-step. As a low maintenance instrument, the cell washer includes easy-to-change pump tubing and an easy-to-remove catch basin, rotor and rotating bowl. The Thermo Scientific CW3 Cell Washer is US Food and Drug Administration (FDA) 510(k) cleared.


Im Rahmen der Vereinbarung werden beide Organisationen zusammenarbeiten, um globale Allianzen und strategische Partnerschaften mit Biopharma-Gruppen und anderen aufzubauen, und so eine Beschleunigung der Onkologie- und Immunonkologie-Studien zu erreichen. Darüber hinaus wird das von Prof. Dr. med. Markus Tolnay geleitete Institut für medizinische Genetik und Pathologie als eine der internationalen Einrichtungen des Programms NGS Companion Dx Center of Excellence fungieren, das den Schwerpunkt auf Forschungsarbeiten und Validierung im Hinblick auf das kommende NGS-Produktportfolio von Thermo Fisher legt. „Das Institut für medizinische Genetik und Pathologie am Universitätsspital Basel ist stolz darauf, als Kompetenzzentrum mit Thermo Fisher eine Partnerschaft einzugehen, insbesondere zu diesem entscheidenden Zeitpunkt, da die wissenschaftliche Forschung an einem Scheitelpunkt steht und möglicherweise wirklich Bedeutendes dahingehend bewirkt, wie man Krebs im 21. Jahrhundert entgegentreten kann", sagte Tolnay. „Durch diese Vereinbarung sind wir zuversichtlich, dass wir gemeinsam große Fortschritte bei der Beschleunigung der klinischen Studienrekrutierung erreichen und neuartige Lösungen entwickeln können, die den Kliniken und den dort zukünftig behandelten Patienten zugutekommen werden." Das Institut für medizinische Genetik und Pathologie am Universitätsspital Basel ist eines der führenden Diagnostikzentren in der Schweiz mit Tausenden von Proben, für die bereits unter Verwendung von NGS Profile erstellt wurden. Außerdem ist das Institut Mitglied des Swiss Excellence Forum, einer strategischen Einflussgröße für die schweizerische Vorgehensweise in Pathologie und Diagnostik. Die enge Partnerschaft zwischen dem Institut, das Teil der ältesten Universität in der Schweiz ist, und Thermo Fisher sowie ein multidisziplinäres Pathologen-Team werden Entdeckungen und Innovationen ermöglichen, die vom ressourcenreichen Forschungsumfeld in Basel für Life Science und Pharmazie profitieren werden. Das wachsende Markenportfolio Oncomine von Thermo Fisher mit gezielter NGS-basierter Krebsforschungsanalytik wird als das zentrale Instrumentarium dienen, auf dessen Grundlage das Labor von Tolnay und die Kooperationspartner Forschungsaktivitäten durchführen werden, die zum Center of Excellence im Bereich Begleitdiagnostik NGS-Entwicklung gehören. „Der Bedarf an neuartigen Technologien, die eines Tages die Testzeiten reduzieren und den Onkologen und Patienten präzise Antworten verschaffen können, kurbelt gegenwärtig die Entwicklung von gezielten NGS-basierten Lösungen an und unterstützt die Präzisionsmedizin", sagte Mark Stevenson, Leiter der Abteilung Life Sciences Solutions für Thermo Fisher Scientific. „Wir sind fest entschlossen, der Partner erster Wahl für die Branche bei diesen Bemühungen zu sein, und Thermo Fisher wird weiterhin neue strategische Allianzen mit führenden globalen Organisationen schmieden, die unsere Vision einer gesünderen Welt mit uns teilen." Über Thermo Fisher Scientific Thermo Fisher Scientific Inc. ist das weltweit führende Unternehmen im Dienst der Wissenschaft mit Umsätzen in Höhe von 18 Milliarden USD und mehr als 55.000 Mitarbeitern weltweit. Unsere Mission lautet, es unseren Kunden zu ermöglichen, die Welt zu einem gesünderen, saubereren und sichereren Ort zu machen. Wir unterstützen unsere Kunden dabei, die Biowissenschaften-Forschung zu beschleunigen, komplexe analytische Herausforderungen zu lösen, die Diagnose bei Patienten zu verbessern und die Laborproduktivität zu erhöhen. Durch unsere herausragenden Marken – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific und Unity Lab Services – bieten wir eine beispiellose Kombination aus innovativen Technologien, bequemen Einkaufsoptionen und umfassender Kundenunterstützung. Weiterführende Informationen finden Sie unter www.thermofisher.com.


Wiseguyreports.Com Adds “Life Science Plastic Bottles -Market Demand, Growth, Opportunities and Analysis of Top Key Player Forecast To 2022” To Its Research Database Global Life Science Plastic Bottles market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Life Science Plastic Bottles in these regions, from 2012 to 2022 (forecast), covering On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into Polystyrene(PS) Bottles Polyethylene (PE) Bottles Polycarbonate (PC) Bottles Polypropylene (PP) Bottles PETG Bottles Others On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Life Science Plastic Bottles for each application, including Laboratory Hospital Pharmaceutical Industry Others If you have any special requirements, please let us know and we will offer you the report as you want. Global Life Science Plastic Bottles Market Research Report 2017 1 Life Science Plastic Bottles Market Overview 1.1 Product Overview and Scope of Life Science Plastic Bottles 1.2 Life Science Plastic Bottles Segment by Type (Product Category) 1.2.1 Global Life Science Plastic Bottles Production and CAGR (%) Comparison by Type (Product Category) (2012-2022) 1.2.2 Global Life Science Plastic Bottles Production Market Share by Type (Product Category) in 2016 1.2.3 Polystyrene(PS) Bottles 1.2.4 Polyethylene (PE) Bottles 1.2.5 Polycarbonate (PC) Bottles 1.2.6 Polypropylene (PP) Bottles 1.2.7 PETG Bottles 1.2.8 Others 1.2.4 Type II 1.3 Global Life Science Plastic Bottles Segment by Application 1.3.1 Life Science Plastic Bottles Consumption (Sales) Comparison by Application (2012-2022) 1.3.2 Laboratory 1.3.3 Hospital 1.3.4 Pharmaceutical Industry 1.3.5 Others 1.4 Global Life Science Plastic Bottles Market by Region (2012-2022) 1.4.1 Global Life Science Plastic Bottles Market Size (Value) and CAGR (%) Comparison by Region (2012-2022) 1.4.2 North America Status and Prospect (2012-2022) 1.4.3 Europe Status and Prospect (2012-2022) 1.4.4 China Status and Prospect (2012-2022) 1.4.5 Japan Status and Prospect (2012-2022) 1.4.6 Southeast Asia Status and Prospect (2012-2022) 1.4.7 India Status and Prospect (2012-2022) 1.5 Global Market Size (Value) of Life Science Plastic Bottles (2012-2022) 1.5.1 Global Life Science Plastic Bottles Revenue Status and Outlook (2012-2022) 1.5.2 Global Life Science Plastic Bottles Capacity, Production Status and Outlook (2012-2022) 7 Global Life Science Plastic Bottles Manufacturers Profiles/Analysis 7.1 Thermo Scientific 7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.1.2 Life Science Plastic Bottles Product Category, Application and Specification 7.1.2.1 Product A 7.1.2.2 Product B 7.1.3 Thermo Scientific Life Science Plastic Bottles Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 7.1.4 Main Business/Business Overview 7.2 Corning 7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.2.2 Life Science Plastic Bottles Product Category, Application and Specification 7.2.2.1 Product A 7.2.2.2 Product B 7.2.3 Corning Life Science Plastic Bottles Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 7.2.4 Main Business/Business Overview 7.3 Kartell 7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.3.2 Life Science Plastic Bottles Product Category, Application and Specification 7.3.2.1 Product A 7.3.2.2 Product B 7.3.3 Kartell Life Science Plastic Bottles Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 7.3.4 Main Business/Business Overview 7.4 Bel-Art 7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.4.2 Life Science Plastic Bottles Product Category, Application and Specification 7.4.2.1 Product A 7.4.2.2 Product B 7.4.3 Bel-Art Life Science Plastic Bottles Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 7.4.4 Main Business/Business Overview 7.5 Wheaton 7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.5.2 Life Science Plastic Bottles Product Category, Application and Specification 7.5.2.1 Product A 7.5.2.2 Product B 7.5.3 Wheaton Life Science Plastic Bottles Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 7.5.4 Main Business/Business Overview 7.6 Qorpak 7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.6.2 Life Science Plastic Bottles Product Category, Application and Specification 7.6.2.1 Product A 7.6.2.2 Product B 7.6.3 Qorpak Life Science Plastic Bottles Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 7.6.4 Main Business/Business Overview 7.7 Sarstedt 7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.7.2 Life Science Plastic Bottles Product Category, Application and Specification 7.7.2.1 Product A 7.7.2.2 Product B 7.7.3 Sarstedt Life Science Plastic Bottles Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 7.7.4 Main Business/Business Overview 7.8 SPL Life Sciences 7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.8.2 Life Science Plastic Bottles Product Category, Application and Specification 7.8.2.1 Product A 7.8.2.2 Product B 7.8.3 SPL Life Sciences Life Science Plastic Bottles Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 7.8.4 Main Business/Business Overview 7.9 SciLabware 7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.9.2 Life Science Plastic Bottles Product Category, Application and Specification 7.9.2.1 Product A 7.9.2.2 Product B 7.9.3 SciLabware Life Science Plastic Bottles Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 7.9.4 Main Business/Business Overview 7.10 Dynalon 7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.10.2 Life Science Plastic Bottles Product Category, Application and Specification 7.10.2.1 Product A 7.10.2.2 Product B 7.10.3 Dynalon Life Science Plastic Bottles Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 7.10.4 Main Business/Business Overview 7.11 NEST Biotechnology 7.12 Guangzhou Jet Bio-Filtration For more information, please visit https://www.wiseguyreports.com/sample-request/1256753-global-life-science-plastic-bottles-market-research-report-2017


News Article | May 4, 2017
Site: www.prnewswire.com

"There is an increased market demand for the unique analytical capabilities of the TMT technology, as well as for service providers with the necessary skills and equipment to perform that type of analysis. We are very excited about growing the use of this technology and having the ability to offer it through CST's service business," said Navid Haghdoost, director, Protein Biology Product Management, Thermo Fisher Scientific. The TMT technology uses tandem mass spectrometry (MS/MS) to provide consistent and accurate simultaneous identification and quantitation of proteins in up to 10 different samples derived from cells, tissues or biological fluids. The technology features an enhanced multiplex capability resulting in fewer missing quantitative values as the level of TMT multiplexing increases. "CST is pleased to license TMT technology from Thermo Fisher Scientific, which will add power to our proteomics services by delivering unparalleled quantitative protein analysis. We expect this technology will enable us to help our pharma and academic customers accelerate their pre-clinical discovery research," said Roberto Polakiewicz, chief scientific officer at CST. For more information about TMT technology, please visit: www.thermofisher.com/TMT About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of $18 billion and more than 55,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive support. For more information, please visit www.thermofisher.com. About CST Cell Signaling Technology (CST) is a private, family-owned company, founded by scientists and dedicated to providing the world's highest quality, innovative, research and diagnostic products to accelerate biological understanding and enable personalized medicine. Our employees operate worldwide from our U.S. headquarters in Massachusetts, and our offices in the Netherlands, China, and Japan. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/new-licensing-program-facilitates-adoption-of-tandem-mass-tag-technology-300450906.html


News Article | April 17, 2017
Site: www.prweb.com

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announces the Gibco™ ExpressionWorld™ virtual conference, the world’s largest online venue for experiencing the latest advances in protein expression in mammalian cells. On May 10, 2017, this interactive forum will connect experts from the worlds of pharma, biotech and academia to share recent discoveries, compelling case studies and best practices in the exciting areas of biologics development and structural biology. The event will also provide attendees with global networking and interactive training opportunities. The virtual event will feature speakers covering topics ranging from: Attendees will receive first-hand knowledge of the newest technologies for high-titer recombinant protein production as well as protein expression system design, workflows, purification, and characterization methods. In between presentations and throughout the entire event, participants will be able to network and collaborate with world-class experts and participate in live chat sessions with leading experts. Attendees may also access interactive virtual training labs and exclusive offers during the event. LabRoots will host the event May 10, log in anytime after 8 am regardless of your time zone. To learn more about this unique event, discover the complete list of speaker or to register for free, click here. ABOUT THERMO FISHER SCIENTIFIC Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of $17 billion and more than 50,000 employees in 50 countries. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive support. For more information, please visit http://www.thermofisher.com. ABOUT LABROOTS LabRoots is the leading scientific social networking website and producer of educational virtual events and webinars. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning, and is a primary source for current scientific news, webinars, virtual conferences, and more. LabRoots has grown into the world’s largest series of virtual events within the Life Sciences and Clinical Diagnostics community.


News Article | April 18, 2017
Site: www.prnewswire.co.uk

CARLSBAD, California, 18 de abril de 2017 /PRNewswire/ -- Thermo Fisher Scientific ha firmado un acuerdo con el Instituto de Genética Médica y Patología del Hospital Universitario de Basilea, Suiza, para establecer a la distinguida institución como primer socio del Next Generation Sequencing Companion Dx Center of Excellence Program (Programa de centro de excelencia de secuenciación de próxima generación y diagnósticos complementarios), una nueva iniciativa diseñada para desarrollar y perfeccionar las pruebas de investigación basadas en NGS de su cartera oncológica Oncomine™ con el propósito de introducirlos eventualmente en la clínica como diagnósticos complementarios. Como parte del acuerdo, ambas organizaciones trabajarán conjuntamente para forjar alianzas internacionales y asociaciones estratégicas con grupos biofarmacéuticos y otros a fin de acelerar los ensayos en oncología e inmuno-oncología. Además, el Instituto de Genética Médica y Patología, gestionado por el doctor en medicina Markus Tolnay, operará como una de las localizaciones internacionales del NGS Companion Dx Center of Excellence Program dedicadas a la investigación y validación de la cartera de productos NGS de Oncomine de Thermo Fisher. "El Instituto de Genética Médica y Patología del Hospital Universitario de Basilea se enorgullece de colaborar con Thermo Fisher Scientific actuando como centro de excelencia durante este momento crucial en el que la investigación científica se encuentra a la puertas de, potencialmente, tener una influencia decisiva en la forma en la que el cáncer puede ser afrontado en el siglo XXI", dijo Tolnay. "Gracias a este acuerdo, estamos seguros de que juntos lograremos avanzar enormemente para acelerar la participación en ensayos clínicos y desarrollar soluciones innovadoras que beneficiarán a los hospitales y a los pacientes a los que tratan en el futuro". El Instituto de Genética Médica y Patología del Hospital Universitario de Basilea es uno de los principales centros de diagnóstico de Suiza –con miles de muestras que ya han sido procesadas utilizando NGS– y forma parte del Swiss Excellence Forum, un 'influenciador' estratégico de estrategia de diagnóstico y patología suiza. La estrecha colaboración entre el instituto, que pertenece a la universidad más antigua de Suiza, Thermo Fisher y un equipo multidisciplinario de patólogos, posibilitará descubrimientos e innovaciones que se beneficiarán del rico entorno de investigación farmacéutica y en ciencias de la vida de Basilea. La creciente cartera de pruebas de investigación oncológica basadas en NGS selectiva bajo la marca Oncomine de Thermo Fisher funcionará como la 'caja de herramientas' central a partir de la que el laboratorio de Tolnay y sus colaboradores llevarán a cabo actividades relativas al centro de excelencia en desarrollo de NGS y diagnóstico complementario. "La demanda de tecnologías novedosas que puedan un día reducir los tiempos de prueba y proporcionar respuestas exactas a oncólogos y pacientes está impulsando el desarrollo de soluciones basadas en NGS selectiva para fomentar una medicina de precisión", declaró Mark Stevenson, presidente de Soluciones de Ciencias de la Vida de Thermo Fisher Scientific. "Estamos comprometidos a ser el socio preferido del sector en esta labor y Thermo Fisher continuará forjando nuevas alianzas estratégicas con organizaciones internacionales líderes que comparten nuestra visión de un mundo más saludable". Acerca de Thermo Fisher Scientific Thermo Fisher Scientific Inc. es el líder mundial al servicio de la ciencia, con unos ingresos de 18 mil millones de dólares estadounidenses y más de 55.000 empleados a nivel internacional. Nuestra misión consiste en capacitar a nuestros clientes para que conviertan el mundo en un lugar más saludable, limpio y seguro. Ayudamos a nuestros clientes a acelerar la investigación en ciencias de la vida, resolver desafíos analíticos complejos, mejorar los diagnósticos de paciente y aumentar la productividad de los laboratorios. A través de nuestras marcas principales –Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific y Unity Lab Services– ofrecemos una inigualable combinación de tecnologías innovadoras, comodidad de compra y asistencia integral. Para obtener más información, visite www.thermofisher.com.


News Article | May 5, 2017
Site: www.prnewswire.com

You can access the live webcast of the presentation via the Investors section of our website, www.thermofisher.com. An audio archive of the webcast will be available through Friday, June 16, 2017. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with revenues of $18 billion and more than 55,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive support. For more information, please visit www.thermofisher.com. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/thermo-fisher-scientific-to-host-analyst-meeting-300452259.html


News Article | April 18, 2017
Site: www.prnewswire.com

CARLSBAD, California, 18 de abril de 2017 /PRNewswire/ -- Thermo Fisher Scientific ha firmado un acuerdo con el Instituto de Genética Médica y Patología del Hospital Universitario de Basilea, Suiza, para establecer a la distinguida institución como primer socio del Next Generation Sequencing Companion Dx Center of Excellence Program (Programa de centro de excelencia de secuenciación de próxima generación y diagnósticos complementarios), una nueva iniciativa diseñada para desarrollar y perfeccionar las pruebas de investigación basadas en NGS de su cartera oncológica Oncomine™ con el propósito de introducirlos eventualmente en la clínica como diagnósticos complementarios. Como parte del acuerdo, ambas organizaciones trabajarán conjuntamente para forjar alianzas internacionales y asociaciones estratégicas con grupos biofarmacéuticos y otros a fin de acelerar los ensayos en oncología e inmuno-oncología. Además, el Instituto de Genética Médica y Patología, gestionado por el doctor en medicina Markus Tolnay, operará como una de las localizaciones internacionales del NGS Companion Dx Center of Excellence Program dedicadas a la investigación y validación de la cartera de productos NGS de Oncomine de Thermo Fisher. "El Instituto de Genética Médica y Patología del Hospital Universitario de Basilea se enorgullece de colaborar con Thermo Fisher Scientific actuando como centro de excelencia durante este momento crucial en el que la investigación científica se encuentra a la puertas de, potencialmente, tener una influencia decisiva en la forma en la que el cáncer puede ser afrontado en el siglo XXI", dijo Tolnay. "Gracias a este acuerdo, estamos seguros de que juntos lograremos avanzar enormemente para acelerar la participación en ensayos clínicos y desarrollar soluciones innovadoras que beneficiarán a los hospitales y a los pacientes a los que tratan en el futuro". El Instituto de Genética Médica y Patología del Hospital Universitario de Basilea es uno de los principales centros de diagnóstico de Suiza –con miles de muestras que ya han sido procesadas utilizando NGS– y forma parte del Swiss Excellence Forum, un 'influenciador' estratégico de estrategia de diagnóstico y patología suiza. La estrecha colaboración entre el instituto, que pertenece a la universidad más antigua de Suiza, Thermo Fisher y un equipo multidisciplinario de patólogos, posibilitará descubrimientos e innovaciones que se beneficiarán del rico entorno de investigación farmacéutica y en ciencias de la vida de Basilea. La creciente cartera de pruebas de investigación oncológica basadas en NGS selectiva bajo la marca Oncomine de Thermo Fisher funcionará como la 'caja de herramientas' central a partir de la que el laboratorio de Tolnay y sus colaboradores llevarán a cabo actividades relativas al centro de excelencia en desarrollo de NGS y diagnóstico complementario. "La demanda de tecnologías novedosas que puedan un día reducir los tiempos de prueba y proporcionar respuestas exactas a oncólogos y pacientes está impulsando el desarrollo de soluciones basadas en NGS selectiva para fomentar una medicina de precisión", declaró Mark Stevenson, presidente de Soluciones de Ciencias de la Vida de Thermo Fisher Scientific. "Estamos comprometidos a ser el socio preferido del sector en esta labor y Thermo Fisher continuará forjando nuevas alianzas estratégicas con organizaciones internacionales líderes que comparten nuestra visión de un mundo más saludable". Acerca de Thermo Fisher Scientific Thermo Fisher Scientific Inc. es el líder mundial al servicio de la ciencia, con unos ingresos de 18 mil millones de dólares estadounidenses y más de 55.000 empleados a nivel internacional. Nuestra misión consiste en capacitar a nuestros clientes para que conviertan el mundo en un lugar más saludable, limpio y seguro. Ayudamos a nuestros clientes a acelerar la investigación en ciencias de la vida, resolver desafíos analíticos complejos, mejorar los diagnósticos de paciente y aumentar la productividad de los laboratorios. A través de nuestras marcas principales –Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific y Unity Lab Services– ofrecemos una inigualable combinación de tecnologías innovadoras, comodidad de compra y asistencia integral. Para obtener más información, visite www.thermofisher.com.


Dans le cadre de cet accord, les deux organisations travailleront ensemble pour créer des alliances mondiales et des partenariats stratégiques avec des groupes biopharmaceutiques et autres et accélérer ainsi les essais en oncologie et en oncologie immunitaire. En outre, l'Institut de génétique médicale et de pathologie, dirigé par le docteur Markus Tolnay, MD, sera l'un des sites du NGS Companion Dx Center of Excellence Program qui s'attachera à mener des recherches sur le portefeuille de produits Oncomine NGS de Thermo Fisher et à les valider. « L'Institut de génétique médicale et de pathologie de l'hôpital universitaire de Bâle est fier de s'associer à Thermo Fisher Scientific en tant que centre d'excellence à ce moment crucial où la recherche médicale est vraisemblablement sur le point de faire toute la différence quant à la manière dont le cancer sera traité au 21è siècle », explique Tolnay. « Grâce à cet accord, nous sommes certains qu'ensemble, nous pourrons réaliser des avancées majeures afin de favoriser la participation aux essais cliniques et de mettre au point des solutions inédites qui profiteront aux hôpitaux et aux patients dont ils s'occuperont à l'avenir ». L'Institut de génétique médicale et de pathologie de l'hôpital universitaire de Bâle est l'un des principaux centres de diagnostique en Suisse, avec des milliers d'échantillons dont le profil a déjà été établi à l'aide du NGS, et est membre du Swiss Excellence Forum, un groupe suisse qui définit la stratégie en matière de pathologie et de diagnostic. Le partenariat étroit entre l'Institut, qui fait partie de la plus vieille université suisse, Thermo Fisher, et une équipe multidisciplinaire de pathologistes, permettra la découverte et des innovations qui seront propices au riche environnement des sciences de la vie et de la recherche pharmaceutique de Bâle. Le portefeuille croissant de produits Oncomine de Thermo Fisher pour les essais ciblés faisant appel au NGS dans la recherche contre le cancer sera la boîte à outils principale avec laquelle le laboratoire du docteur Tolnay et ses collaborateurs mèneront des activités en rapport avec le Centre d'excellence pour la mise au point d'un NGS comme diagnostique d'accompagnement. « La demande pour de nouvelles technologies qui permettront un jour de réduire la durée des essais et de fournir des réponses aux oncologues et aux patients stimule la mise au point de solutions GNS ciblées permettant de favoriser une médecine de précision », ajoute Mark Stevenson, président des solutions pour les sciences de la vie chez Thermo Fisher Scientific. « Dans le cadre de cette initiative, nous entendons être le partenaire privilégié, et Thermo Fisher continuera de créer de nouvelles alliances stratégiques avec des grandes organisations mondiales qui partagent notre vision d'un monde plus sain ». A propos de Thermo Fisher Scientific Thermo Fisher Scientific Inc. est le leader mondial qui sert la science, avec un chiffre d'affaires de 18 milliards de dollars et plus de 55 000 employés à travers le monde. Notre mission consiste à permettre aux clients de rendre le monde plus sain, plus propre et plus sûr. Nous aidons nos clients à accélérer la recherche dans les sciences de la vie, à relever des défis analytiques complexes, à améliorer les diagnostics des clients et à accroître la productivité des laboratoires. Avec nos grandes marques, Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific et Unity Lab Services, nous offrons une combinaison inégalée de technologies innovantes, de facilité d'achat et de soutien complet. Pour de plus amples informations, rendez-vous sur www.thermofisher.com.


News Article | May 7, 2017
Site: marketersmedia.com

Research Alloys Co. Inc., a company that buys and sells scrap metal in Columbus, Ohio, is proud to announce the launch of a new website to advertise its service to local and national customers. The new website boasts an easy to use navigational interface, coding for mobile responsiveness, and a pricing guide for customer to view scrap metal pricing. In addition, the website provides useful tools for those looking to buy and sell metal of all different types. More information and to view their new website, the company encourages the public to visit: http://www.researchalloys.com/ Research Alloys Co. Inc. is a family run business with over forty years’ of experience in the scrap metal / metal recycling industry. It is run by Joe and John Cusato, the first and second generation owners of the business, who pride themselves on offering great service and instruction in the buying and selling of various types of metal. As part of this goal, Research Alloys Co. offers visitors to their site the chance to view current live metal prices. All a website visitor will have to do is click on the “Current Metal Prices” link at the top of the site. Anyone wanting to buy or sell scrap metal in the Columbus, Ohio area can find a huge range of the types of metals that the company can purchase and sell via their new website. The company frequently purchases, sells, and analyzes the following metals: Inconel, Nickel, Molybdenum, Nickel Cobalt, Titanium, Tungsten Carbide, Tantalum, Niobium, Gold, Silver, Platinum, Aluminum, Tin, Copper, Brass, Bronze, and Stainless Steel. People with specific types of metal to sell or identify may request to have their metal analyzed via the new corporate website to schedule for metal analysis using the Thermo Scientific Niton XL2 analyzer. The metal analyzer is used to identify metal types and help those trying to sell or purchase metal. The company encourages the public to contact them through the new corporate website for all services. On top of this, there is an online contact form to request an appointment for scrap metal removal from residential or commercial construction sites. Customers can also call the company directly (614) 224-4404. The staff are on hand to answer any questions, and help with all scrap metal needs. For more information, please visit http://www.researchalloys.com

Loading Thermo Scientific collaborators
Loading Thermo Scientific collaborators